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Open access under the ElsSulfated polysaccharides are good candidates for drug discovery in the treatment of herpetic infections.
Agaricus brasiliensis (syn A. subrufescens, A. blazei) is a Basidiomycete fungus native to the Atlantic forest
region of Southeastern Brazil. Herein we report the chemical modiﬁcation of a polysaccharide extracted
from A. brasiliensis mycelia to obtain its sulfated derivative (MI-S), which presented a promising inhibi-
tory activity against HSV-1 [KOS and 29R (acyclovir-resistant) strains] and HSV-2 strain 333, with selec-
tivity indices (SI = CC50/IC50) higher than 439, 208, and 562, respectively. The mechanisms underlying this
inhibitory activity were scrutinized by plaque assay with different methodological strategies. MI-S had no
virucidal effects, but inhibited HSV-1 and HSV-2 attachment, penetration, and cell-to-cell spread, as well
as reducing the expression of HSV-1 ICP27, UL42, gB, and gD proteins. MI-S also presented synergistic
antiviral effect with acyclovir. These results suggest that MI-S presents multiple modes of anti-HSV
action.
 2011 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Herpes Simplex Virus types 1 and 2 (HSV-1 and HSV-2) are
human neurotropic viruses usually associated with infections of
the skin and mucosae of different locations, most commonly
the oral and genital regions. Although infections are often sub-
clinical, HSV can cause mild to severe diseases, especially in neo-
nates and immunocompromised individuals. Currently, there is
no cure for the persistent infection, and prolonged therapy with
the available antiherpes drugs has induced the emergence of
drug-resistant virus strains. Moreover, HSV has been described
as a risk factor for HIV infection (Roizman et al., 2007). This sce-
nario has triggered the search for new antiherpetic agents, espe-
cially those with mechanisms of action different from that of
nucleoside analogs, the major class of antiviral agents used for
the management of HSV infections. Besides, a treatment based
on the combination of different antiviral agents can be consid-
ered a promising approach to increase antiviral selectivity while
simultaneously enabling the reduction of the active concentra-
tions of the drugs (Chou, 2006).Virologia Aplicada, Departa-
pus Universitário Trindade,
5207; fax: +55 48 3721 9258.
imões).
evier OA license.Many synthetic or naturally occurring sulfated polysaccharides
from different species of marine algae, bacteria, fungi, and animals
have been previously shown to have antiviral activity against hu-
man and animal viruses (Ghosh et al., 2009). In the case of fungi,
cell wall polysaccharides have been chemically modiﬁed to in-
crease their solubility and enhance their biological activities (Liu
et al., 2010), including their antiviral action (Zhang et al., 2004).
The pharmacological effects of Agaricus brasiliensis, a Basidio-
mycete fungus native to the Brazilian Atlantic forest region, have
been mainly related to the presence of polysaccharides and pro-
tein–polysaccharide complexes (Firenzuoli et al., 2008). Concern-
ing its previous antiviral evaluation, Sorimachi et al. (2001)
showed that the ethanolic fractions of A. brasiliensis mycelium
and fruiting bodies inhibited HSV, poliovirus, and Western equine
encephalitis virus replication. The inhibition of HSV-1 and herpes
bovine virus by an aqueous extract of A. brasiliensis fruiting bodies
was also demonstrated by Bruggemann et al. (2006). Additionally,
both aqueous and ethanolic fruiting bodies extracts and an isolated
polysaccharide from this species displayed antiviral activity
against poliovirus 1, as reported by Faccin et al. (2007).
Considering that fungal biomass is an important source of cell
wall polysaccharides and that sulfated compounds are promising
antiviral agents, this study attempted to produce a sulfated deriv-
ative of a polysaccharide obtained from A. brasiliensis mycelia.
Since this compound presented a potential anti-HSV activity, its
mechanism of action was also evaluated.
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2.1. Fungal material
The fruiting bodies of Agaricus brasiliensisWasser strain UFSC 51
(syn A. subrufescens, A. blazei) were collected in Biguaçu, Santa Cat-
arina State, Southern Brazil. The characterization of the species was
performed by Dr. Maria Alice Neves, and a voucher specimen (FLOR
11 797) was deposited in the FLOR Herbarium (Universidade Fed-
eral de Santa Catarina). The mycelium of A. brasiliensiswas isolated
and cultivated on potato dextrose agar (PDA) (Oxoid, UK) at 25 C
during 7 days. The liquid inoculum was produced by transference
of mycelial disks to ﬂasks containing Melin-Norkrans Modiﬁed
medium (MNM) (Marx, 1969) and cultivated at 25 C during
10 days. Mycelia were ﬁltered and fragmented in 300 mL of NaCl
0.8%. The inoculum was then added to MNM in an airlift bioreactor
(5 L) and cultivated during 7 days at 26 C. The liquid culture was
centrifuged and the mycelial biomass was dehydrated at 55 C un-
til constant weight.
Agaricus brasiliensis polysaccharide was isolated as previously
described (Camelini et al., 2005), with minor modiﬁcations. Fifty
grams of dried mycelial biomass were blended twice with ﬁve vol-
umes of distilled water and reﬂuxed at 100 C for 3 h. The material
was ﬁltered under vacuum through a Whatman n42 ﬁlter paper.
Three volumes of ethanol were added to the ﬁltrate. The mixture
was maintained at 4 C for 24 h and centrifuged (1100 g, 10 min).
The mycelial polysaccharide was freeze-dried and designated as
MI.
To produce the sulfated derivative, MI was sulfated using the
pyridine-chlorosulfonic acid reagent as described by Zhang et al.
(2003). After sulfation, resulting polysaccharides were dialyzed
through a 5 kDa molecular weight cut-off membrane (Spectrum
Laboratories, Rancho Dominguez, CA) against distilled water and
freeze-dried yielding the sulfated derivative (MI-S).
MI and MI-S were characterized by spectroscopic methods
[Fourier transform infrared (FTIR) and 13C Nuclear magnetic reso-
nance (13C NMR)] and elemental analyses (C, H, O, S). Determina-
tion of homogeneity and molecular weight (Mw) was carried out
by high-performance gel ﬁltration chromatography (HPGFC) using
a Perkin Elmer series 200 equipment coupled with a RI detector,
using a gel ﬁltration column (TSK-Gel 5000 PW 7.8  300 mm con-
nected to a TSK PWH 5  7 mm guard column; Tosoh, Japan). Sam-
ples were eluted with 0.2 M NaCl mobile phase at a ﬂow rate of
1 mL/min. Mean Mw was estimated by comparison with retention
times of standard dextrans.2.2. Cells and viruses
Vero cells (ATCC:CCL 81) were grown in minimum essential
medium (MEM), supplemented with 10% fetal bovine serum, pen-
icillin (100 U/mL), streptomycin (100 lg/mL), and amphotericin B
(25 lg/mL). Cell cultures were maintained at 37 C in a humidiﬁed
5% CO2 atmosphere chamber. The virus strains used were: HSV-1
KOS and 29 R (Faculty of Pharmacy, University of Rennes, France),
and HSV-2 333 (Department of Clinical Virology, Göteborg Univer-
sity, Sweden). Virus titers were determined by plaque assay and
expressed as plaque forming units (PFU/mL) (Burleson et al., 1992).2.3. Antiherpes evaluation
The cytotoxicity of samples was determined by the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) as-
say (Mosmann, 1983). Brieﬂy, conﬂuent Vero cells were exposed
to different sample concentrations for 72 h. The medium was
then substituted by the MTT solution and incubated for 4 h. Afterdissolution of formazan crystals, optical densities were read
(540 nm) and the concentration of each sample that reduced cell
viability by 50% (CC50) was calculated based on untreated controls.
Subsequently, the potential antiherpetic activity was evaluated
by the plaque reduction assay as previously described (Silva et al.,
2010). Monolayers of Vero cells grown in 24-well plates were in-
fected with 100 PFU per well of each virus for 1 h at 37 C. Treat-
ments were performed by adding samples either simultaneously
with the virus (simultaneous treatment) or after the virus infection
(post-infection treatment). Cells were subsequently covered with
CMC medium (MEM containing 1.5% carboxymethylcellulose)
and incubated for 72 h. Cells were then ﬁxed and stained with
naphthol blue black and viral plaques was counted. The concentra-
tion of each sample required to reduce the plaque number by 50%
(IC50) was calculated by standard method (Burleson et al., 1992).
Acyclovir (ACV), dextran sulfate (DEX-S), and heparin (HEP) were
purchased from Sigma (St. Louis, MO) and used as positive con-
trols. IC50 and CC50 values were estimated by linear regression of
concentration–response curves generated from the data. The selec-
tivity index (SI = CC50/IC50) was calculated for each sample.
2.4. Evaluation of the mechanism of anti-HSV action
The virucidal assay was conducted as described by Ekblad et al.
(2006), with minor modiﬁcations. Mixtures of equal sample vol-
umes (20 lg/mL) and 4  105 PFU of HSV-1 (KOS and 29-R) or
HSV-2 333 in serum-free MEM were co-incubated for 20 min at 4
or 37 C. Samples were then diluted to non-inhibitory concentra-
tions (1:1000) to determine the residual infectivity by plaque
reduction assay as described above. Ethanol 70% (v/v) served as a
positive control.
The attachment and penetration assays followed the procedures
described by Silva et al. (2010). In the attachment assay, pre-
chilled Vero cell monolayers were exposed to viruses (100 PFU
per well), in the presence or absence of the samples. After incuba-
tion for 2 h at 4 C, samples and unabsorbed viruses were removed
by washing with cold phosphate-buffered saline (PBS) and cells
were overlaid with CMC medium. Further procedures were the
same as described above for the plaque reduction assay.
In the penetration assay, viruses (100 PFU per well) were ad-
sorbed for 2 h at 4 C on pre-chilled cells. After the removal of un-
bound viruses, the temperature was shifted to 37 C to allow
penetration. Then, the cells were treated with different concentra-
tions of pre-warmed samples, and incubated for 1 h at 37 C.
Unpenetrated viruses were inactivated with citrate-buffer (pH
3.0). Cells were washed with PBS and covered with CMC medium.
The percentage of inhibition was calculated based on the reduction
of plaque number as mentioned previously.
Time-of-addition study was performed by virus yield reduction
assay as reported by Carlucci et al. (1999), with some modiﬁca-
tions. Brieﬂy, monolayers of Vero cells were inoculated with
HSV-1 at a MOI (multiplicity of infection) of 0.04, incubated for
60 min at 4 C and 30 min at 37 C to ensure synchronous viral rep-
lication. After removing virus inoculum, cells were maintained at
37 C and treated with MI-S (20 lg/mL), DEX-S (20 lg/mL), or
ACV (2 lg/mL) at 2, 4, 8, 12, 16, and 20 h post-infection (p.i.). After
a 24 h period, cells were lysed by freeze-thawing three times and
cellular debris were removed by centrifugation. Subsequently,
virus titration was carried out by plaque assay. The percentage of
viral inhibition of each sample treatment was calculated by com-
paring it with virus titers of untreated controls.
The effect of tested samples on HSV cell-to-cell spread was
investigated as described by Ekblad et al. (2010). In brief, different
concentrations of MI-S, ACV, or DEX-S were added to Vero cells 1 h
after their infection with 100 PFU per well of HSV, and the
plates were incubated throughout the entire period of plaque
Fig. 1. 13C-NMR spectrum of MI (Agaricus brasiliensis mycelial polysaccharide). 13C
NMR analysis of MI (60 mg, dissolved in D2O) was performed at 25 C with VARIAN
Unity Plus spectrometer operating at 100,582 MHz (9.4 Tesla), using TSPA-d4 as
external reference.
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20 viral plaques formed in the absence (viral control) or the pres-
ence of different concentrations of each sample concentration.
Images were captured using a cooled digital camera coupled to
an Olympus BX41 microscope and the area of each plaque was
determined using the Image J software (http://rsb.info.nih.gov/ij/).
2.5. Western blotting analysis
Westernblottinganalysiswasperformedaspreviouslydescribed
(Kuo et al., 2001). Brieﬂy, monolayers of Vero cells were inoculated
or not with HSV-1 KOS at a MOI of 0.1. Plates were incubated for
60 min at 4 C and 30 min at 37 C to ensure synchronous viral rep-
lication. Then, infected cells were treated with MI-S (20 lg/mL),
DEX-S (20 lg/mL) or ACV (2 lg/mL) at 1, 4, or 8 h p.i., and the plates
were incubated for 18 h. Next, cells were lysed and protein quantiﬁ-
cation was carried out (Bradford, 1976). Each sample (5 lg of pro-
tein) was separated electrophoretically on a 12% SDS–PAGE gel
and electroblotted onto polyvinylidene diﬂuoride (PVDF) mem-
branes. After blocking, membranes were incubated overnight with
either anti-ICP27 (1:700, Millipore, Billerica, MA), or anti-UL42
(1:1000, Millipore), or anti-gB (1:5000, Santa Cruz Biotechnology,
Santa Cruz, CA), or anti-gD (1:5000, Santa Cruz Biotechnology). After
incubationwith thecorresponding secondaryantibodies conjugated
to horseradish peroxidase, protein bandswere revealed by chemilu-
minescence on X-ray ﬁlms (IBF, Brazil) using Pierce ECL substrate
(Thermo Scientiﬁc, Waltham, MA) according to the Manufacturer’s
protocol. The relative amounts of protein in the detectedbandswere
quantiﬁed by Image J software. The anti-b-actin antibody was used
as a control for total protein loading.
2.6. Synergistic effect in combination with acyclovir
Potential synergistic effects of MI-S in combination with ACV
was evaluated by plaque reduction assay, according to experimen-
tal design proposed by Chou (2006). Therefore, each drug alone or
in combination was tested at an equipotency ratio, based on its
corresponding IC50 value. The degree of interaction between MI-S
and ACV was calculated through combination index (CI) equation,
based on the median-effect principle of the mass-action law, using
Calcusyn software (version 2.1, Biosoft). According to the CI the-
orem, CI values <1, =1, and >1 indicate synergism, additive effect,
and antagonism, respectively.3. Results
3.1. Characterization of A. brasiliensis polysaccharides
Assignment of 13C NMR spectrum (Fig. 1) was based on the pre-
viously published spectrum by Mizuno and colleagues (1999).
Anomeric signals (C1) at d 105.1 and 101.9 ppm were assigned to
b-glucopyranosyl and b-mannopyranosyl residues, respectively.
The signals at d 98.1 and 94.3 ppm were assigned to the corre-
sponding reducing end-groups. The characteristic resonances of
C2, C3, C4, C5, and C6 of b-(1? 2)-linked components were ob-
served at d 78.2, 73.7, 71.8, 77.9, and 62.9 ppm, respectively. The
signals of b-(1? 3)-linked components were assigned as C2
(75.0), C3 (86.6), C4 (71.9), C5 (76.3), and C6 (62.9). This result sug-
gested that MI is a glucomannan with a main chain of b-1,2-linked
D-mannopyranosyl residues and b-D-glucopyranosyl-3-O-b-D-glu-
copyranosyl residues as side chains. A symmetric single peak was
obtained by gel permeation chromatography of MI-S, suggesting
that the polymer is homogeneous. Based on calibration curves with
standard dextrans, the apparentMw of MI-S was 86 kDa. In the MI-
S spectrum, obtained by FTIR analyses, two new absorption bandsappeared at 1253 and 810 cm1 (data not shown). These bands are
related to S@O and C–S–O sulfate groups respectively, conﬁrming
that sulfation had actually occurred (Silverstein et al., 2005). In
addition, the content of sulfur determined by elemental analyses
was 14.77% and 10.72% for MI-S and DEX-S, respectively.
3.2. Antiherpetic activity
The cytotoxicity and antiviral activity results were used to cal-
culate the selectivity index of each sample (SI = CC50/IC50) (Table 1).
The data show that MI presented no antiviral activity, whereas MI-
S inhibited both HSV-1 and HSV-2 replication, indicating that
chemical sulfation was required for the antiviral activity. Since
the simultaneous treatment was more efﬁcient than the p.i. treat-
ment, a direct inactivation of viral particles or inhibition of virus
replication at the initial phases of the viral replication cycle could
be involved.
Preincubation of virus suspensions with MI-S or controls (DEX-S
and ACV), at 4 and 37 C, had no signiﬁcant inactivating effects
(data not shown) on HSV-1 KOS and HSV-2 333 at the tested con-
centrations (20 lg/mL), which suppressed 100% of viral replication
in the plaque reduction assay. These results indicate that the viru-
cidal effect does not seem to be involved in the MI-S antiviral activ-
ity detected.
Along with the adsorption, the effect of MI-S on HSV penetra-
tion was also investigated (Table 2). The results demonstrated that
MI-S, as well as DEX-S and HEP, strongly inhibited attachment of
all viruses tested. Similarly to DEX-S, MI-S was also able to prevent
penetration of all HSV strains into the cells, whereas HEP was
much less effective for the HSV-2 strain.
To further clarify which steps of HSV infection are targeted by
the samples, a time-of-addition study was performed (Fig. 2). The
observed inhibition of HSV-1 KOS yield was higher than 50%, even
when MI-S was added 16 h p.i. This might indicate that MI-S exerts
some effect on virus cycle step(s), other than adsorption and pen-
etration, as veriﬁed by the following results.
After penetration, HSV-1 expresses immediate early genes
about 2–3 h p.i., early genes about 7 h p.i., and late genes after
the viral DNA synthesis has begun. Western blotting analyses were
carried out to evaluate if the MI-S antiviral mechanism was related
to the inhibition of HSV-1 protein expression. To reduce the inter-
ference with any prior step of each protein expression stage in the
viral replication cycle, samples were added at 1, 4, and 8 h p.i. for
analysis of a, b, and c proteins, respectively (Fig. 3). The results
shown in Fig. 3B represent the quantiﬁcation of each band in rela-
tion to the b-actin expression. As shown in Fig. 3, MI-S signiﬁcantly
Table 1
Cytotoxicity and antiherpetic activity of Agaricus brasiliensis polysaccharides.
Sample CC50 IC50 (SI)
Simultaneous treatment Post-infection treatment
HSV-1 (KOS) HSV-1 (29R) HSV-2 (333) HSV-1 (KOS) HSV-1(29R) HSV-2 (333)
MI 3352.11 ± 206.64 NI NI NI NI NI NI
MI-S 2415.29 ± 389.21 1.24 ± 0.05 (1948) 1.59 ± 0.25 (1519) 0.39 ± 0.17 (6193) 5.50 ± 0.58 (439) 11.62 ± 1.01 (208) 4.30 ± 0.36 (562)
HEP >2,500 1.15 ± 0.30 (>2174) 2.01 ± 0.38 (>1244) 0.58 ± 0.01 (>4310) 12.68 ± 1.13 (>197) NT 8.06 ± 1.46 (>310)
DEX-S 2465.53 ± 200.13 0.59 ± 0.01 (4179) 0.92 ± 0.08 (2680) 0.47 ± 0.16 (5246) 6.23 ± 0.96 (396) 11.92 ± 1.31 (207) 15.36 ± 2.79 (160)
ACV >2500 NI NI NI 0.51 ± 0.05 (>4902) 760.00 ± 80 (>3) 3.91 ± 0.41 (>639)
CC50, 50% cytotoxic concentration for Vero cells (lg/mL); IC50, 50% inhibitory concentration (lg/mL); Selectivity index values (SI = CC50/IC50) are presented between
parenthesis; NI, no inhibitory activity; NT, not tested; MI, A. brasiliensis mycelial polysaccharide; MI-S, sulfated A. brasiliensis mycelial polysaccharide; HEP, heparin; DEX-S,
dextran sulfate; ACV, acyclovir. These values represent the mean ± SD of three independent experiments.
Table 2
Effect of Agaricus brasiliensis polysaccharides on HSV adsorption and penetration.
Sample Inhibitory effect (IC50)
Attachment Penetration
HSV-1 (KOS) HSV-1 (29 R) HSV-2 (333) HSV-1 (KOS) HSV-1 (29 R) HSV-2 (333)
MI NI NI NI NI NI NI
MI-S 0.10 ± 0.01 0.26 ± 0.03 0.05 ± 0.01 1.04 ± 0.06 0.49 ± 0.10 1.21 ± 0.28
HEP 0.33 ± 0.04 0.62 ± 0.03 0.07 ± 0.01 13.34 ± 3.64 25.74 ± 2.64 17.99 ± 4.06
DEX-S 0.12 ± 0.04 0.11 ± 0.00 0.02 ± 0.00 0.85 ± 0.13 0.82 ± 0.11 0.69 ± 0.09
ACV NI NI NI NI NI NI
IC50, 50% inhibitory concentration (lg/mL); NI, no inhibitory activity; MI, A. brasiliensis mycelial polysaccharide; MI-S, Sulfated A. brasiliensis mycelial polysaccharide; HEP,
heparin; DEX-S, dextran sulfate; ACV, acyclovir; These values represent the mean ± SD of three independent experiments.
Fig. 2. Time-of-addition study. Percentage of inhibition of MI-S (sulfated Agaricus
brasiliensis mycelial polysaccharide), ACV (acyclovir), and DEX-S (dextran sulfate)
when added at different times after HSV-1 (KOS strain) infection. Each point
represents the mean value ± SD of two independent experiments.
F.T.G.S. Cardozo et al. / Antiviral Research 92 (2011) 108–114 111reduced the expression of ICP27, UL42, and gB. Moreover, the com-
bination of MI-S and acyclovir (lane 4) reduced all the proteins
expression more strongly than these compounds tested separately.
The reduction of HSV-1 and HSV-2 cell-to-cell spread was eval-
uated by comparing viral plaque areas between treated cells and
untreated controls. Considering that signiﬁcant differences in pla-
ques sizes were only observed at concentrations higher than the
IC50 values of all tested samples (data not shown), as well as the
small number of plaques at this condition, an additional experi-
ment was performed with samples at concentrations equivalent
to their IC50 values. Mean plaque areas for each treatment and un-
treated controls are shown in Fig. 4. Regarding to HSV-1 (KOS
strain), MI-S reduced the viral plaque size more extensively than
did DEX-S and ACV. Although HSV-2 lateral diffusion was signiﬁ-
cantly reduced by all tested samples, MI-S resulted in the smallest
mean plaque areas for both viruses. Even though the tested con-
centrations in this experiment were different, the reduction of viral
plaque numbers was similar (50%).Given the fact that MI-S seemed to act in a different way than
acyclovir, the potential synergistic effects between them were
tested at different concentrations (Table 3). Since all combinations
tested presented CI values less than 1, synergistic anti-HSV-1 and
HSV-2 effects of MI-S with ACV were demonstrated.4. Discussion
In order to evaluate the inﬂuence of the treatment period on the
anti-HSV activity of MI-S, the plaque number reduction assay was
performed under two different conditions. As shown in Table 1,
MI-S was considerably more effective by simultaneous rather than
post-infection treatment. The same result was observed for the
other sulfated polysaccharides tested, HEP and DEX-S, as expected
due to their similar nature. These results are in agreement with
those of other authors who tested different sulfated polysaccha-
rides, such as carrageenans (Carlucci et al., 1999), fucoidans (Kar-
makar et al., 2010), and sulfated b-glucans (Zhang et al., 2004),
and found a stronger inhibition of HSV replication in the simulta-
neous treatment with these compounds than in post-infection
treatments.
Although similar IC50 values were obtained for MI-S and HEP in
the simultaneous treatment, we have not found an anticoagulant
activity for MI-S at a 100% inhibitory concentration (data not
shown), which represents an advantage for an antiherpes agent
with these chemical features. Moreover, in the post-infection treat-
ment, the inhibitory effect of MI-S was stronger than those of HEP
for HSV-1 (KOS strain) and HSV-2, and of DEX-S for HSV-2. Differ-
ences among these results may be related to their structural diver-
sity since, differently fromMI-S and DEX-S, HEP is a linear polymer
(Rabenstein, 2002), with a lower molecular mass (18 kDa) than
either MI-S (86 kDa) or DEX-S (500 kDa). Furthermore, the higher
content of sulfur present in MI-S (14.77%) can be correlated to its
stronger effect at inhibiting HSV-2 than DEX-S (10.79%). Indeed,
the antiherpetic properties of sulfated polysaccharides are deter-
mined by a combination of structural features such as molecular
Fig. 3. Effect of MI-S (sulfated Agaricus brasiliensis mycelial polysaccharide) on
HSV-1 (KOS strain) protein expression. Treated and untreated cells were analyzed
by SDS–PAGE/Western blotting using speciﬁc antibodies for viral (ICP27, UL42, gB,
or gD) and cellular (b-actin) proteins. (A) Lanes 1 to 4: HSV-1 infected cells treated
with MI-S (20 lg/mL), dextran sulfate (DEX-S, 20 lg/mL), acyclovir (ACV, 2 lg/mL),
and MI-S (20 lg/mL) plus ACV (2 lg/mL), respectively. Samples were added at 1, 4,
and 8 h p.i. for analyses of a, b, and c HSV proteins, respectively. Lane 5: untreated
viral control; Lane 6: untreated cellular control. (B) The graph indicates the ratio of
each viral protein to b-actin protein. Statistical analysis (one-way ANOVA followed
by Newman-Keuls test) demonstrated signiﬁcant differences in relation to viral
controls with p values <0.05 () and <0.01 (). The results are representative of two
independent experiments.
Fig. 4. Inhibition of HSV-1 and HSV-2 cell-to-cell spread by MI-S (sulfated Agaricus
brasiliensismycelial polysaccharide), DEX-S (dextran sulfate), and ACV (acyclovir) at
their corresponding IC50 concentrations. The interference on cell-to-cell spread of
MI-S, DEX-S, or ACV was evaluated at 5.50, 6.23, and 0.51 lg/mL for HSV-1 KOS, and
at 4.30, 15.36, and 3.91 lg/mL for HSV-2 333, respectively. Results were expressed
as average area of viral plaques developed in sample-treated cells and compared to
untreated controls. Statistical analysis (one-way ANOVA followed by Dunnett’s test)
demonstrated signiﬁcant differences in relation to the controls with p values <0.05
(), <0.01 (), and <0.005 (). Values shown represent means of three indepen-
dent experiments.
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tion of uncharged portions (Ghosh et al., 2009).
Sulfated polysaccharides may present an antiherpetic activity
through different mechanisms, including virucidal effects. In this
study, however, MI-S showed no virucidal effects, indicating that
the antiherpes activity detected by the plaque reduction assay
was due to the interference with some step(s) of the HSV repli-
cation cycle. By contrast, Bruggemann et al. (2006) have shown
an HSV-1 virucidal activity for an aqueous extract of A. brasilien-
sis, but they used different methodologies for virucidal evalua-
tion and extract preparation, which did not include the
sulfation reaction. Still, other studies on the antiviral activity of
sulfated polysaccharides have similarly reported no virucidal ef-
fects (Adhikari et al., 2006; Chattopadhyay et al., 2007, 2008;
Karmakar et al., 2010; Matsuhiro et al., 2005; Zhu et al., 2006),
or the virucidal action was detected only at concentrations high-
er than their IC50 values (Carlucci et al., 1999; Mazumder et al.,
2002; Zhu et al., 2004).
Among the steps of HSV infection and replication, attachment
and entry have been considered as potential targets. The ﬁndings
presented in Table 2 are in agreement with those published by
other authors, who stated that the mechanism underlying the
antiherpes activity of polysaccharides, especially sulfated ones,
may be related to the inhibition of HSV adsorption (Carlucciet al., 1999; Eo et al., 2000; Zhang et al., 2007). Since there
was no detectable loss of HSV residual infectivity at 4 C in the
presence of MI-S, the virucidal mechanism in the adsorption as-
says was dismissed. Table 2 shows that MI-S and DEX-S dis-
played IC50 values lower than 1.21 lg/mL, whereas HEP
showed values higher than 13.34 lg/mL. Since HEP was the only
tested sulfated polysaccharide with a linear chain, it can be sug-
gested that the presence of lateral branches could be important
for the inhibition of the herpes virus penetration. The lack of
inhibition of viral adsorption and penetration by the non-sul-
fated polysaccharide (MI) conﬁrmed that the presence of sulfate
groups is required for such activities.
In addition to the inhibition of HSV replication at 1 h p.i. treat-
ment, MI-S presented inhibitory activity even when added at long-
er times after infection (Fig. 2), suggesting an action in post-entry
events. This hypothesis was investigated by Western blotting anal-
yses, in which a considerable reduction of a (ICP27), b (UL42), and
c (gB) HSV-1 proteins expression was found when MI-S was added
at 1, 4, and 8 h p.i., respectively. Differently, infected cells treated
with MI-S resulted in a slight reduction of gD expression. As for
now, considering the performed experiments, the authors are un-
able to point out the reason for differences observed in reduction
of expression of the late proteins gB and gD. Furthermore, the de-
tected general reduction of protein production by MI-S could be
associated with a secondary effect on another step of the viral cy-
cle, as observed for ACV, for which inhibition of protein expression
was due to an indirect effect on suppression of viral DNA replica-
tion. Although we are not aware of previous reports indicating
the inhibition of HSV protein expression by sulfated polysaccha-
rides, one study described the reduction of HIV protein expression
by a sulfated oligosaccharide as well as by dextran sulfate (Artan
et al., 2010).
Since an efﬁcient dissemination of virus has an important role
in its infectivity, the inhibition of viral intercellular diffusion is
an attractive target for new antiviral drugs. In the plaque size
reduction assay, MI-S signiﬁcantly reduced plaque areas. Recently,
Ekblad and colleagues (2010) have shown the inhibition of HSV
cell-to-cell spread by a sulfated tetrasaccharide.
Here, a synergistic effect of MI-S with ACV was also found, sup-
porting the results of their combination by Western blotting assay.
These ﬁndings suggest that MI-S can be used either alone or in
combination with ACV for the treatment of herpes infections, espe-
Table 3
Synergistic effects of combination of sulfated Agaricus brasiliensis polysaccharide (MI-S) with acyclovir (ACV) on anti-HSV activity.
Compounds combination ratio Sample concentration (lg/mL) Mean percentage of inhibition (%) MI-S + ACV Experimental CI values Description (graded symbols)
MI-S ACV
HSV-1 (KOS)
4  IC50 22.00 2.04 100.00 0.398 Synergism (+ + +)
2  IC50 11.00 1.02 100.00 0.199 Strong synergism (+ + + +)
1  IC50 5.50 0.51 100.00 0.099 Strong synergism (+ + + +)
0.5  IC50 2.75 0.26 64.00 0.431 Synergism (+ + +)
0.25  IC50 1.38 0.13 39.00 0.383 Synergism (+ + +)
HSV-2 (333)
4  IC50 17.20 15.64 100.00 0.372 Synergism (+ + +)
2  IC50 8.60 7.82 100.00 0.186 Strong synergism (+ + + +)
1  IC50 4.30 3.91 86.86 0.472 Synergism (+ + +)
0.5  IC50 2.15 1.96 59.79 0.646 Synergism (+ + +)
0.25  IC50 1.08 0.98 19.59 0.816 Slight synergism (+)
CI, combination index, a quantitative measure calculated by Calcusyn Software. This index quantiﬁes the interaction between the tested compounds as described by Chou
(2006). In detail, CI from 0.10 to 0.30 means strong synergism, 0.30–0.70 means synergism, 0.70–0.85 means moderate synergism, and 0.85–0.90 means slight synergism.
Obtained values represent the mean of two independent experiments.
F.T.G.S. Cardozo et al. / Antiviral Research 92 (2011) 108–114 113cially those in which patients do not respond to ACV. Some other
HSV entry inhibitors have already been reported to present syner-
gistic effects with ACV. For example, a complex polysaccharide–
protein from Ganoderma lucidum (Eo et al., 2000), docosanol (Mar-
celletti, 2002), and oxyresveratrol (Chuanasa et al., 2008).
In summary, our ﬁndings indicate that MI-S interferes with var-
ious steps of the HSV replication cycle, mainly adsorption and pen-
etration, but also viral protein expression, as well as with HSV cell-
to-cell spread. Taking into account the prospect of an economically
feasible biotechnological production of this polysaccharide and its
promising antiherpetic activity herein reported, further investiga-
tion is needed to clarify the potential of such compound for clinical
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